Statistical modeling demonstrates tumor progression rates and mammography diagnostic accuracy in screening programs, highlighting quantitative tools for assessing preclinical cancer duration.
H. H. Chen, S. W. Duffy, Laszlo Tabar, A Markov Chain Method to Estimate the Tumour Progression Rate from Preclinical to Clinical Phase, Sensitivity and Positive Predictive Value for Mammography in Breast Cancer Screening, Journal of the Royal Statistical Society. Series D (The Statistician), Vol. 45, No. 3 (1996), pp. 307-317
No takes yet. Share an insight, caveat, or question.
Chen et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: